查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1514104

全球產前診斷市場

Prenatal Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球產前診斷市場（美國）預計將達到 142 億美元

2023年全球產前診斷市場估計為61億美元，預計2030年將達到142億美元，2023-2030年分析期間複合年成長率為12.7%。非侵入性檢測是本報告分析的細分市場之一，預計複合年成長率為 15.2%，到分析期結束時將達到 106 億美元。分析期間，侵入式檢測領域的複合年成長率預計為 7.1%。

美國市場預計16億美元，中國預計複合年成長率17.2%

預計 2023 年美國產前診斷市場規模將達 16 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達36億美元，2023-2030年分析期間複合年成長率為17.2%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 8.0% 和 10.7%。在歐洲，德國的複合年成長率預計約為 9.7%。

全球產前診斷市場趨勢及促進因素總結

產前診斷已成為現代產科護理的重要組成部分，提供有關胎兒健康和狀況的重要資訊。這些診斷對於管理妊娠、預測併發症以及確保胎兒和孕產婦健康至關重要。產前診斷在檢測先天性異常方面發揮重要作用，先天性異常佔周產期死亡的很大一部分。現有技術，從超音波檢測等非侵入性方法到羊膜穿刺術和絨毛膜絨毛取樣（CVS）等侵入性方法，可以進行詳細評估和早期干預。這些方法使醫療保健提供者能夠管理懷孕的最後幾週，規劃與出生相關的併發症，為潛在的新生兒問題做好準備，並就繼續懷孕做出明智的決定。

無創技術，例如超音波檢查，使用高頻聲波對胎兒和母親的內部結構進行成像。儘管這種方法很安全，並且最早可以在懷孕 6 週時進行可視化，但其檢測特定異常（例如與唐氏症相關的異常）的能力有限。母體血液取樣提取胎兒 DNA 是分析母體血液中胎兒 DNA 來檢測染色體異常的另一種非侵入性方法，但前提是存在足夠多的胎兒才能獲得準確的結果。羊膜穿刺術和 CVS 等侵入性技術透過提取胎兒細胞進行染色體、生化和分子分析來提供更詳細的資訊。儘管這些手術存在相關風險，包括胎兒死亡和母體 Rh 過敏，但它們為了解胎兒的遺傳和發育健康提供了重要的見解。

產前診斷的成長是由技術進步和對其益處的認知不斷提高所推動的。診斷影像技術和基因檢測能力的進步大大提高了產前診斷的準確性和可靠性。人工智慧 (AI) 和機器學習在這些過程中的整合進一步提高了診斷準確性，並能夠及早、準確地檢測潛在問題。此外，對個人化醫療和預防保健的需求不斷成長，導致產前診斷技術的廣泛採用。支持性法律規範、非侵入性選擇的增加以及病患教育的改善也有助於擴大這些服務。隨著技術的不斷發展，產前診斷的範圍將會擴大，為胎兒的健康提供更全面的了解，並有望為母親和嬰兒帶來更好的結果。

受訪企業範例（共43例）

  • ANGLE Plc
  • Berry Genomics Co. Ltd.
  • BGI Genomics
  • F. Hoffmann-La Roche Ltd.
  • Hologic Inc.
  • Illumina Inc.
  • Laboratory Corporation of America（R）Holdings
  • Lifecodexx AG
  • Natera Inc.
  • Quest Diagnostics Inc.
  • Ravgen Inc.
  • Sequenom Inc.

目錄

第1章調查方法

第2章執行概述

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 歐洲其他地區
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP-7675

Global Prenatal Diagnostics Market to Reach US$14.2 Billion by 2030

The global market for Prenatal Diagnostics estimated at US$6.1 Billion in the year 2023, is expected to reach US$14.2 Billion by 2030, growing at a CAGR of 12.7% over the analysis period 2023-2030. Non-Invasive Test, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$10.6 Billion by the end of the analysis period. Growth in the Invasive Test segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 17.2% CAGR

The Prenatal Diagnostics market in the U.S. is estimated at US$1.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.6 Billion by the year 2030 trailing a CAGR of 17.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.0% and 10.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.7% CAGR.

Global Prenatal Diagnostics Market - Key Trends & Drivers Summarized

Prenatal diagnostics have become essential in modern obstetrics, providing critical information about the health and condition of an unborn fetus. These diagnostics are vital for managing pregnancy, anticipating complications, and ensuring the well-being of both the fetus and the mother. Prenatal diagnostics play a significant role in detecting congenital anomalies, which account for a substantial percentage of perinatal deaths. The techniques available, ranging from non-invasive methods like ultrasonography to invasive procedures such as amniocentesis and chorionic villus sampling (CVS), allow for detailed assessment and early intervention. These methods enable healthcare providers to manage the final weeks of pregnancy, plan for birth-related complications, prepare for potential newborn issues, and make informed decisions regarding the continuation of the pregnancy.

Non-invasive techniques such as ultrasonography use high-frequency sound waves to create images of the fetus and internal structures of the mother. This method is safe and allows visualization as early as six weeks gestation, although its ability to detect certain abnormalities, like those associated with Down syndrome, is limited. Maternal blood sampling for fetal DNA is another non-invasive method that analyzes fetal DNA present in the mother's blood to detect chromosomal anomalies, though it can be challenging to obtain sufficient fetal DNA for accurate results. Invasive techniques like amniocentesis and CVS provide more detailed information by extracting fetal cells for chromosomal, biochemical, and molecular analysis. Despite the risks associated with these procedures, such as fetal loss and maternal Rh sensitization, they offer critical insights into the genetic and developmental health of the fetus.

The growth of prenatal diagnostics is driven by advancements in technology and increased awareness of their benefits. Enhanced imaging techniques and genetic testing capabilities have significantly improved the accuracy and reliability of prenatal diagnostics. The integration of artificial intelligence (AI) and machine learning in these processes further refines diagnostic precision, enabling earlier and more accurate detection of potential issues. Additionally, the rising demand for personalized healthcare and preventive medicine has led to broader adoption of prenatal diagnostic techniques. Supportive regulatory frameworks, increased availability of non-invasive options, and improved patient education have also contributed to the expansion of these services. As technology continues to evolve, the scope of prenatal diagnostics is expected to broaden, providing even more comprehensive insights into fetal health and facilitating better outcomes for both mothers and their babies.

Select Competitors (Total 43 Featured) -

  • ANGLE Plc
  • Berry Genomics Co. Ltd.
  • BGI Genomics
  • F. Hoffmann-La Roche Ltd.
  • Hologic Inc.
  • Illumina Inc.
  • Laboratory Corporation of America(R) Holdings
  • Lifecodexx AG
  • Natera Inc.
  • Quest Diagnostics Inc.
  • Ravgen Inc.
  • Sequenom Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Prenatal Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Early and Accurate Prenatal Screening Spurs Market Growth
    • Advances in Genetic Testing Technologies Propel Innovation in Prenatal Diagnostics
    • Rising Adoption of Non-Invasive Prenatal Testing (NIPT) Expands Market Potential
    • Increasing Awareness and Focus on Maternal and Fetal Health Drives Demand
    • Product Innovations and Customization Strengthen Business Case for Prenatal Diagnostics
    • Expanding Use of Prenatal Diagnostics in High-Risk Pregnancies Sustains Market Growth
    • Government Initiatives and Investments in Healthcare Infrastructure Spur Market Expansion
    • Increasing Preference for Safe and Reliable Diagnostic Procedures Drives Demand
    • Strategic Collaborations and Partnerships Strengthen Market Position for Key Players
    • Rising Awareness and Implementation of Advanced Imaging Technologies Generate Market Opportunities
    • Rising Awareness and Implementation of Advanced Imaging Technologies Generate Market Opportunities
    • Growing Adoption of Prenatal Diagnostics in Emerging Markets Propels Market Growth
    • Focus on Reducing Healthcare Costs and Improving Pregnancy Outcomes Drives Demand for Prenatal Diagnostics
    • Influence of Digital Health and Telemedicine Expands Market Reach
    • Healthcare Providers' Focus on Early Detection and Prevention Throws Spotlight on Prenatal Diagnostics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Prenatal Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Prenatal Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Prenatal Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Prenatal Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Non-Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Non-Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Non-Invasive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Invasive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Trisomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Trisomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Trisomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Micro-Deletions Symptoms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Micro-Deletions Symptoms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Micro-Deletions Symptoms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Prenatal Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Prenatal Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Prenatal Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Prenatal Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Prenatal Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Prenatal Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Prenatal Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Prenatal Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Prenatal Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Prenatal Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Prenatal Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Prenatal Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION